Qingdao Shengshi Zhiyang Import and Export Co., Ltd.
 
 
PE 22-28 TREK-1 Neuroprotective Peptide
  • Brand:Shengshizhiyang
  • Model:1*1
  • Purity:99%
  • Cas:1159861-00-3
  • Createtime: 2026-07-08
  • Updatetime: 2026-06-30
Product Details
One box 10vials
useage Heptapeptide for mood regulation and brain neurogenesis lab research
deliveryInfo
appearance White lyophilized powder
aliasen
supplyCapacity 100G/Day
harbor Hong Kong
minorder 1G
Payment method Alibaba, PayPal, USDT, bank card, Western Union remittance
Delivery date 10 days
Whatsapp +86 155 1138 8892

Name: PE 22-28

Alias: Optimized Spadin Heptapeptide, TREK-1 Channel Inhibitor
CAS Registry number: 1801959-12-5
Sequence: Gly-Val-Ser-Trp-Gly-Leu-Arg-NH?
Molecular Formula: C??H??N??O?
Molecular Weight: 773.88 Da
Purity: ≥99% (by HPLC)
Appearance: White lyophilized powder
Packing: 10mg*10vials/box
Product Group: Mood-regulating neuroprotective heptapeptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.


Brief Introduction:

PE 22-28 is an optimized synthetic seven-amino-acid peptide truncated from natural Spadin, exclusively for laboratory research. It acts as a high-selective TREK-1 two-pore potassium channel inhibitor with IC?? = 0.12 nM, blocking excessive K? outflow to raise neuronal excitability in mood-related brain regions such as hippocampus and raphe nucleusMedChemExp.... It boosts serotonergic signal transmission, accelerates hippocampal neurogenesis and relieves oxidative neuronal damage, showing fast antidepressant and anti-anxiety effects far quicker than traditional SSRIs without long latency periodmyotrope.c.... It also suppresses NF-κB inflammatory pathway, reduces pro-inflammatory cytokines, alleviates cerebral ischemia-reperfusion injury and improves cognitive function under stress, widely applied in mood disorder, neurogenesis, neuroprotection and novel antidepressant pharmacology research.


Main Research Applications:

Depression & anxiety research: Used in cell and animal models to study TREK-1 channel regulation and rapid mood improvement mechanisms.
Hippocampal neurogenesis research: Suitable for exploring neural progenitor cell proliferation and synaptic plasticity promotion pathways.
Cerebral ischemia protection research: Applied to investigate neuronal anti-apoptosis and brain injury recovery effects.
Stress-induced cognitive impairment research: For comparative analysis of stress hormone balance and memory restoration.

Novel antidepressant peptide pharmacology research: Study TREK-1 targeted pathway distinct from serotonin reuptake inhibitors.


Note:
This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.

Contact
Phone:+852 5426 4167
Tel:--
Whatsapp:852 5426 4167